Kancera
  • Svenska
  • Home
  • About us
    • Statement from the CEO
    • Business model
    • Management
    • Board of directors
  • Research&Development
    • R&D portfolio
    • Fractalkine project
      • The problem
      • The solution
      • This is how KAND567 works
      • Next step
      • The future
    • Scientific publications
  • Investors
    • The share
    • Press releases
    • Reports
      • Principles and definitions
    • Calendar
    • Corporate Governance
      • Articles of association
      • General meeting
      • Board of directors committee
      • Board of directors
      • CEO and management
      • Auditors
    • Subscribe
  • Press
    • Press releases
    • Images and logos
    • Subscribe
    • News
    • Press contact
  • Contact
    • Careers
Select Page
  • Svenska
  • Press releases
  • Images and logos
  • Subscribe
  • News
  • Press contact

NEWS

2019

The Nobel Price in Physiology or Medicine 2019 rewards discoveries that form the basis for our drug development projects (2019-10-08)

Labiotech refers to Kancera’s R&D presented at the World Congress of Cardiology/ESC (2019-10-07)

Commissioned analyst report of Kancera AB by Carlsquare (2019-05-29)

2018

Marie Sklodowska-Curie PhD student position at Kancera AB on the role of the fractalkine system in inflammatory conditions (2018-12-20).

Kancera chemistry contributed to one of the new drugs approved in 2017 against cancer (2018-02-01)

2017

Abstract to a presentation on ASH about KAN0439834 (2017-11-09)

The PFKFB3 project is presented at “The 6th EU-US conference on repair of endogenous DNA damage” (2017-09-24)

Kancera’s Fractalkine project appears in BIO Buzz (2017-06-27)

Drug Discovery Today covers Kancera’s Fractalkine project (2017-04-10)

Kancera project update February 2017

2015

Poster at ASH on ROR-inhibitors

Presentation by CEO Thomas Olin in Paris at BIO-Europe Spring 2015

PRESS CONTACT

Thomas Olin, CEO thomas.olin@kancera.com Tel: +46 (0)850 12 60 80

 

Download our reports here

Read all press releases

Check out the latest news

Click on the image to download our latest report

Kancera AB

Karolinska Institutet Science Park
Nanna Svartz Väg 4
SE-171 65 Solna, Sweden
Tel: +46 (0)850 12 60 80

This site uses cookies. Follow the link below for more information and our web policy:
  • Website policy
  • Svenska
Copyright 2017 Kancera AB